GLYCAEMIC VARIABILITY AND TIME IN RANGE IN TYPE 1 DIABETES PATIENTS ON REAL TIME CONTINUOUS GLUCOSE MONITORING AND INSULIN INJECTIONS VERSUS SENSOR-AUGMENTED INSULIN PUMP THERAPY

被引：0
|
作者：
Beato-Vibora, P. [1 ]
Lazaro-Martin, L. [1 ]
Gallego-Gamero, F. [1 ]
机构：
[1] Badajoz Univ Hosp, Endocrinol, Badajoz, Spain
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
210
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [41] Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy
    Ly, Trang T.
    Nicholas, Jennifer A.
    Retterath, Adam
    Davis, Elizabeth A.
    Jones, Timothy W.
    [J]. DIABETES CARE, 2012, 35 (07) : 1462 - 1465
  • [42] Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes
    Ruan, Yue
    Thabit, Hood
    Leelarathna, Lalantha
    Hartnell, Sara
    Wilinska, Malgorzata E.
    Tauschmann, Martin
    Dellweg, Sibylle
    Benesch, Carsten
    Mader, Julia K.
    Holzer, Manuel
    Kojzar, Harald
    Evans, Mark L.
    Pieber, Thomas R.
    Arnolds, Sabine
    Hovorka, Roman
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (10): : 1485 - 1489
  • [43] Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes: Results from the STAR 3 Randomized Trial
    Kamble, Shital
    Weinfurt, Kevin P.
    Schulman, Kevin A.
    Reed, Shelby D.
    [J]. MEDICAL DECISION MAKING, 2013, 33 (02) : 215 - 224
  • [44] THE COST-EFFECTIVENESS OF INITIATING SENSOR-AUGMENTED PUMP THERAPY VERSUS MULTIPLE DAILY INJECTIONS OF INSULIN IN ADULTS WITH TYPE 1 DIABETES: EVALUATING A TECHNOLOGY IN EVOLUTION
    Kamble, S.
    Perry, B. M.
    Shafiroff, J.
    Schulman, K. A.
    Reed, S. D.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A82 - A82
  • [45] Multiple Insulin Injections Versus Insulin Pump Therapy to Diabetes Mellitus Type 1
    Liberatore, Raphael Del Roio
    Bellini Ribeiro, Maria Estela
    Martinelli, Carlos Eduardo
    Custodio, Rodrigo
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [46] PROJECTION OF HEALTH-ECONOMIC BENEFITS OF SENSOR-AUGMENTED PUMP (SAP) VERSUS INSULIN PUMP THERAPY ALONE (CSII), IN TYPE 1 DIABETES PATIENTS, IN DENMARK
    Roze, S.
    Duteil, E.
    Delbaere, A.
    De Portu, S.
    Brandt, A. S.
    Ridderstrale, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A79 - A80
  • [47] Insulin pump therapy in pregnant women with type 1 diabetes: intermittently scanned glucose monitoring vs sensor augmented pump
    Sola, C.
    Mariaca Riveros, K.
    Milad, C.
    Roca, D.
    Amor, A.
    Gimenez, M.
    Bellart, J.
    Vinagre, I.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S244 - S245
  • [48] Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France
    Roze, Stephane
    Smith-Palmer, Jayne
    Valentine, William
    Payet, Vincent
    de Portu, Simona
    Papo, Natalie
    Cucherat, Michel
    Hanaire, Helene
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (02) : 75 - 84
  • [49] First user experience with an integrated insulin pump and real-time continuous glucose monitoring system in German patients with type 1 diabetes
    Danne, Thomas
    Liebl, Andreas
    Reichel, Andreas
    Kordonouri, Olga
    [J]. DIABETES, 2006, 55 : A194 - A195
  • [50] Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial
    Tumminia, Andrea
    Crimi, Salvatore
    Sciacca, Laura
    Buscema, Massimo
    Frittitta, Lucia
    Squatrito, Sebastiano
    Vigneri, Riccardo
    Tomaselli, Letizia
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (01) : 61 - 68
12345